Perthera report
WebIntroduction. Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with the 5-year survival ranging from 37.4% for local disease to 2.9% for distant disease. 1 The incidence of pancreatic cancer continues to rise and it is projected to become the second leading cause of cancer-related death by 2030. 2 Despite ongoing efforts to improve early … WebAt Perthera we strive to surround ourselves with a Board of Directors who can help us grow our business and improve our processes. Our board is made up of recognized leaders …
Perthera report
Did you know?
WebThe Perthera Report provides oncologists with a comprehensive view of their patient’s medical and treatment history, as well as their patient’s molecular information. Using the … WebPerthera will analyze results and provide a Perthera Report.Report includes: A comprehensive analysis of your cancer using molecular data; Possible treatment options that match your cancers genetic profile, including specialists, clinical trials and other available treatments. Discuss treatment options provided by Perthera with your physician.
WebPerthera.ai’s patented process provides physicians with an easy-to-use report with therapy options ranked by a unique approach combining existing evidence, real-world evidence (RWE), a patient’s past medical and treatment history, and their multi-omic molecular profile. The Perthera.ai approach to Precision Oncology combines AI capabilities ... Web6. apr 2024 · MCLEAN, Va., April 6, 2024 /PRNewswire/ -- Perthera, Inc. announced today that it has been building its management team over the past few months to provide an integrated, turnkey "enabling ...
Web2. mar 2024 · Perthera coordinated molecular testing and delivered a report of molecularly tailored treatment recommendations intended for patients and their treating oncologists. Perthera's patient registry included an optional consent to collect real-world outcomes longitudinally for research.
Web28. jún 2024 · Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through its Perthera Report, which precisely matches cancer patients with multiple therapeutic options ranked by highest probability of best outcome.
Web3. feb 2024 · Perthera.ai is a pioneer in personalized AI-assisted Oncology decision support with it's patented ranked therapy options presented in the Perthera Report that is created by our Precision Oncology ... green ridge lawn careWebPerthera.ai uses the power of multi-omic cancer profiling and the advanced analytics of our proprietary Precision Oncology Platform to enhance oncologists' decision-making by providing a Perthera Report with matched and ranked … flyweb replacement bulbWebPerthera AI is a precision oncology company that has pioneered the use of advanced multi-omic molecular analysis combined with a patient-centered "data lake" of comprehensive outcomes and medical ... greenridge lane new plymouthWeb12. mar 2024 · Within the platform, Perthera organizes a molecular profiling protocol for patients, including ordering necessary tumor sequencing, immunohistochemistry, and … fly web plus fly trapWeb25. mar 2016 · Patients with pancreatic cancer can obtain molecular tumor profiling through the Pancreatic Cancer Action Network’s Know Your Tumor SM precision medicine initiative, a partnership with Perthera, a personalized medicine service company that facilitates the multi-omic profiling and generates the reports to patients and physicians. 1,2. At the 2016 … greenridge memory careWeb11. júl 2024 · Multi-omic molecular testing results were obtained from a cohort of 713 pancreatic adenocarcinoma patients who received a Perthera Report describing the actionability of their molecular findings. greenridge lithonia gaWebThe PERTHERA REPORT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description: Medical information; Providing medical … flyweb insect trap